Abstract P21: Tenecteplase: As First Choice “Give and Go” Stroke Thrombolysis Treatment
Sign Up to like & getrecommendations! Published in 2021 at "Stroke"
DOI: 10.1161/str.52.suppl_1.p21
Abstract: Tenecteplase (TNK) is more fibrin specific and has longer activity duration than Alteplase (ALT). Compared to ALT, recent acute stroke treatment studies have found TNK at doses up to 0.4mg/kg to ha... read more here.
Keywords: first choice; treatment; p21 tenecteplase; tenecteplase first ... See more keywords